List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
4132-CL-0001An Open-Label, Dose-Escalation/Expansion Phase 1 Study of ASP4132 Given Orally to Patients with Advanced Refractory Solid Tumors and Lymphoma English


English


QUICK SEARCH

USEFUL LINKS